SCHEMBL24256219

SCHEMBL24256219

CC1(C)OC2CC3CCC(CO)(O3)C2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17286213 0.71 ASGR1 (0.35) —
SCHEMBL21479787 0.71 ASGR1 (0.35) —
SCHEMBL13992838 0.69 SMN1; SMN2 (0.31) —
SCHEMBL18723082 0.69 CA2 (0.35) —
SCHEMBL9462261 0.68 — —
SCHEMBL24256624 0.66 ASGR1 (0.40) —
SCHEMBL22640959 0.62 — —
SCHEMBL17583763 0.59 EPHX2 (0.35) —
SCHEMBL16840440 0.59 EPHX2 (0.35) —
SCHEMBL21683322 0.59 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035997-A1 IN VIVO ASSEMBLY OF ASGPR BINDING THERAPEUTICS AVILAR THERAPEUTICS, INC. (US) 2022-02-17 — — WO disclosed
Send feedback